NCT07292558
Achieving Health in Emerging Adults With Diabetes (AHEAD) Program: A Clinical Trial Designed to Understand if Participation in a Clinical Program Developed Specifically to Support Emerging Adults With Type 1 Diabetes Leads to Improved Diabetes Outcomes.
Recruiting
NAAges 16–19InterventionalTreatmentUniversity of British ColumbiaInvestigator-initiated
~306 participants
Updated 2025-12-30 on ClinicalTrials.gov
What's tested:AHEAD Program
At a glance
Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Hemoglobin A1c (HbA1c)
Measured over From enrollment (baseline clinic visit: 0 months) to the end of intervention period (6th clinic visit: 15-24 months).
Conditions
Where it's being run
1 sites across 1 statesWashington1
Study leadership
- Faisal S Malik, MD, MSc · PRINCIPAL_INVESTIGATOR · University of British Columbia
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Hemoglobin A1c (HbA1c)From enrollment (baseline clinic visit: 0 months) to the end of intervention period (6th clinic visit: 15-24 months).
HbA1c laboratory measurement.